Excuse me if I misread who the quote in question i
Post# of 148170
As to CYDY'S current management, I wish I could agree with you. Nader did do his job, taking the stock from 29 cents to over $3, and, as high as $10. But neither he or anyone currently employed by the company has the experience and, apparently, the competence needed to bring FDA approval to fruition. The nitty gritty of asking the right questions, presenting data in a cogent fashion, and on, and on, and on, comes with the background of having been previously involved in the process.
Beyond and above the preceding, I have been willing to overlook the CEO's checkered past, but he by virtue of that, draws detractors like flies to a picnic. It's time for a change.